Poster
Circulating Tumor Cells (CTCs) With Small-Cell Like Features are Prevalent in Metastatic Castration Resistant Prostate Cancer (mCRPC) and Show Selective Pharmacodynamic Reductions in Patients Treated With Platinum Therapy but not an ARSi or Taxane
Author
Howard I. Scher
Condition
Metastatic Castration Resistant Prostate Cancer
Source url
s3://convoke-optic-posters/2024-05-10/20200515_ScherHI_NESC_LandscapeFINAL-1.pdf
2 organizations
1 product
Product
PlatinumOrganization
Memorial Sloan Kettering Cancer CenterOrganization
Epic Sciences, Inc.